Myeloid derived suppressor and dendritic cell subsets are related to clinical outcome in prostate cancer patients treated with prostate GVAX and ipilimumab

Overview of attention for article published in Journal for Immunotherapy of Cancer, September 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
Above-average Attention Score compared to outputs of the same age and source (61st percentile)

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 1,694 followers.

MDSC and DC subsets related to clinical outcome in prostate cancer pts treated with GVAX and ipilimumab http://t.co/wmFzydT3ha @sitcancer

MDSC and DC subsets related to clinical outcome in prostate cancer pts treated with GVAX and ipilimumab http://t.co/wmFzydT3ha @sitcancer

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.